UC San Diego Health, the region’s only academic medical center, delivers world-class care and translates groundbreaking research into promising new treatments for patients.
Researchers used an experimental intravenous phage therapy to successfully treat and cure colleague Tom Patterson, PhD, who was near death from a multidrug-resistant bacterial infection.
UC San Diego Health is the first hospital system in the region to offer a novel treatment option for patients with prostate cancer that has spread throughout the body and has not responded to other therapeutics.
Researchers used mouse models to explore how diet and feeding patterns affect the rodents’ intestinal microbes, and obesity and type 2 diabetes.
Novel therapy option shown to extend the lifespan and improve quality of life for certain patients
UC San Diego Health has been recognized as a top performer in the 2022 Quality Leadership Ranking by Vizient, Inc. This is the fourth consecutive year that UC San Diego Health has been ranked among the top ten academic health systems in the United States.
Medpage Today, September 21
Becker's Hospital Review, September 23
MSN Money, September 24
Dermatology Digest, September 24
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
